Eric Skolnik - Apr 22, 2022 Form 4 Insider Report for BLONDER TONGUE LABORATORIES INC (BDRL)

Role
SVP - CFO
Signature
/s/ Eric Skolnik
Stock symbol
BDRL
Transactions as of
Apr 22, 2022
Transactions value $
$2,452
Form type
4
Date filed
4/25/2022, 04:27 PM
Previous filing
Apr 11, 2022
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDRL Common Stock, par value $0.001 Award $529 +766 +1.63% $0.69 47.8K Apr 22, 2022 Direct F1
transaction BDRL Common Stock, par value $0.001 Award $1.92K +2.79K +5.82% $0.69 50.6K Apr 22, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).
F2 Pursuant to the participation in the Second Amended and Restated Executive Stock Purchase Plan between the reporting person and the issuer, on the date on which a portion of the reporting person's net cash compensation has been reduced, the issuer issued the number of shares indicated. The number of shares of common stock issued represents the quotient of (i) the portion of the net cash compensation reduction divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).